US · MHUA
Meihua International Medical Technologies Co., Ltd.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Yangzhou 225000
- Website
- meihuamed.com
Price · as of 2024-12-31
—
Market cap 7.52M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $54.68 | — |
| Intrinsic Value(DCF) | $0.36 | — |
| Graham-Dodd Method(GD) | $7.79 | — |
| Graham Formula(GF) | $3.15 | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $5.67 | $8.38 | |||
| 2020 | $7.46 | $15.32 | |||
| 2021 | $7.20 | $78.55 | $12.58 | $9.70 | $21.48 |
| 2022 | $15.12 | $315.89 | $0.00 | $7.23 | $2.02 |
| 2023 | $0.73 | $82.81 | $0.28 | $8.54 | $1.16 |
| 2024 | $0.32 | $54.68 | $0.31 | $7.79 | $3.15 |
AI valuation
Our deep-learning model estimates Meihua International Medical Technologies Co., Ltd.'s (MHUA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $54.68
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.36
— upside
Graham-Dodd
$7.79
— upside
Graham Formula
$3.15
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| MHUA | Meihua International Medi… | $0.24 | 7.52M | +23,099% | +53% | +3,205% | +1,234% | 0.81 | 0.06 | 0.09 | 0.05 | — | 0.06 | 34.36% | 14.77% | 11.19% | 7.10% | 7.91% | 6.05% | 0.05 | 9.50 | 5.26 | 4.80 | -0.51 | -1837.00% | -19.00% | -70159.00% | 165.58% | 0.54 | 10.08% | 0.00% | 0.00% | 2.28% | 0.05 | 0.05 | 0.01 | 2.51 |
| ADIL | Adial Pharmaceuticals, In… | $0.33 | 7.26M | — | — | — | — | -1.06 | 3.43 | — | -1.23 | — | 3.43 | 0.00% | — | — | -323.80% | -1052.66% | -269.86% | 0.00 | — | 4.16 | 3.84 | 0.45 | -8695.00% | — | — | -49.65% | -7.09 | -879.58% | 0.00% | 0.00% | 6.62% | -1.23 | -1.47 | — | -18.87 |
| BFRI | Biofrontera Inc. | $1.09 | 11.63M | +13,983% | -66% | — | — | -0.29 | 1.14 | 0.14 | -0.28 | — | 1.15 | 50.12% | -46.14% | -47.61% | -384.98% | -281.81% | -70.99% | 1.11 | -8.17 | 1.72 | 0.93 | 0.07 | -7527.00% | 949.00% | -5851.00% | -203.55% | -0.85 | -169.15% | 0.00% | 0.00% | 99.29% | -0.24 | -0.40 | 0.11 | -7.68 |
| CHEK | Check-Cap Ltd. | $1.35 | 7.9M | — | — | — | — | -0.19 | -3.24 | — | -0.49 | -0.43 | -3.24 | 0.00% | — | — | -226.19% | 1959.89% | -198.07% | -0.09 | -2883.22 | 0.15 | 0.15 | -0.01 | 4333.00% | — | -9995.00% | -0.17% | 0.00 | 0.60% | 0.00% | 0.00% | 0.00% | -0.18 | -570.68 | — | -861.86 |
| LUCY | Innovative Eyewear, Inc. | $1.58 | 7.23M | +1,568% | +28,515,951% | — | — | -0.81 | 0.69 | 3.84 | 0.16 | — | 0.73 | 13.15% | -484.20% | -474.60% | -106.00% | -557.55% | -96.74% | 0.00 | — | 12.52 | 10.38 | 0.35 | -5904.00% | 4199.00% | 1643.00% | -111.49% | -9.14 | -493.01% | 0.00% | 0.00% | 0.00% | 0.16 | 0.18 | -0.76 | 0.10 |
| PAVM | PAVmed Inc. | $0.35 | 6.09M | +306,826% | +29,017% | +172,865% | +1,028,629% | 0.23 | -2.66 | 2.21 | 1.26 | — | -2.66 | -101.60% | -1485.38% | 1328.58% | -100.94% | -2590.22% | 89.14% | -12.77 | -988.60 | 0.06 | 0.03 | 1.03 | -10541.00% | 2215.00% | -3571.00% | -507.27% | -0.95 | -1956.86% | 0.00% | 0.00% | 0.00% | -0.84 | -1.11 | 12.45 | -17.53 |
| POAI | Predictive Oncology Inc. | $6.40 | 4.65M | +581% | +7% | — | -90% | -8.59 | -460.28 | 57.43 | -9.24 | — | -225.96 | 49.12% | -673.69% | -751.39% | -269.18% | -631.77% | -112.02% | -10.52 | — | 0.62 | 0.41 | -0.14 | -3563.00% | -878.00% | -1859.00% | -11.78% | -3.05 | -634.35% | 0.00% | 0.00% | 0.00% | -8.65 | -8.62 | 58.29 | -47.25 |
| SBFM | Sunshine Biopharma, Inc. | $1.77 | 8.06M | +2,910% | +44,030,507% | — | — | -0.33 | 0.07 | 0.05 | 1.37 | — | 0.08 | 30.60% | -16.67% | -14.72% | -22.97% | -54.65% | -17.73% | 0.04 | -662.41 | 4.11 | 2.15 | 1.69 | -9792.00% | 4475.00% | 5530.00% | -885.54% | -1.98 | -146.04% | 0.00% | 0.00% | 187.20% | 1.21 | 0.48 | -0.20 | -1.74 |
| SSKN | STRATA Skin Sciences, Inc… | $1.70 | 7.09M | +3,178% | -40% | — | — | -9.66 | 19.60 | 2.90 | -37.52 | — | -32.12 | 56.85% | -27.58% | -30.05% | -114.22% | -51.01% | -25.80% | 3.31 | -4.39 | 1.13 | 0.86 | -3.23 | -1613.00% | 61.00% | -7385.00% | -1.49% | 0.01 | -8.11% | 0.00% | 0.00% | 0.00% | -11.52 | -73.65 | 3.18 | -7.58 |
About Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
- CEO
- Wang Xin
- Employees
- 619
- Beta
- 0.70
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.36 ÷ —) − 1 = — (DCF, example).